https://novapharmanews.com/us/news/sunlight-glp-1-2026-fda-decision-compounded-semaglutide 2026-06-01T15:06:29.942Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z Sunlight GLP-1 2026: FDA's Decision on Compounded Semaglutide semaglutide, GLP-1 https://novapharmanews.com/uploads/articles/sunlight-glp-1-2026-fda-decision-compounded-semaglutide.webp Sunlight GLP-1 2026: FDA's Decision on Compounded Semaglutide https://novapharmanews.com/us/news/ophthalmology-pipeline-milestones-q2-2026 2026-06-01T15:06:20.968Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z Ophthalmology Pipeline Milestones for Q2 2026: What to Expect https://novapharmanews.com/uploads/articles/ophthalmology-pipeline-milestones-q2-2026.webp Ophthalmology Pipeline Milestones for Q2 2026: What to Expect https://novapharmanews.com/us/news/fda-permanent-ban-compounded-glp-1s 2026-06-01T15:06:55.961Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z FDA's Permanent Ban on Compounded GLP-1s: What It Means for Pharma GLP-1 https://novapharmanews.com/uploads/articles/fda-permanent-ban-compounded-glp-1s.webp FDA's Permanent Ban on Compounded GLP-1s: What It Means for Pharma https://novapharmanews.com/us/news/2025-drug-approvals-biopharma-resilience 2026-06-01T08:54:49.560Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z 2025 Drug Approvals: Biopharma's Resilience Amidst Challenges https://novapharmanews.com/uploads/articles/2025-drug-approvals-biopharma-resilience.webp 2025 Drug Approvals: Biopharma's Resilience Amidst Challenges https://novapharmanews.com/us/news/top-10-takeover-targets-2026 2026-06-01T14:04:55.454Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z Top 10 Takeover Targets of 2026: Market Analysis https://novapharmanews.com/uploads/articles/top-10-takeover-targets-2026.webp Top 10 Takeover Targets of 2026: Market Analysis https://novapharmanews.com/us/news/fda-eases-restrictions-peptides-drug-approvals 2026-06-01T15:08:13.884Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z FDA Eases Restrictions on Peptides: Implications for Drug Approvals https://novapharmanews.com/uploads/articles/fda-eases-restrictions-peptides-drug-approvals.webp FDA Eases Restrictions on Peptides: Implications for Drug Approvals https://novapharmanews.com/us/news/fda-approvals-oncology-jan-mar-2026 2026-06-01T15:06:59.550Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z FDA Approvals in Oncology: January-March 2026 oncology https://novapharmanews.com/uploads/articles/fda-approvals-oncology-jan-mar-2026.webp FDA Approvals in Oncology: January-March 2026 https://novapharmanews.com/us/news/fda-peptides-bulk-drug-compounding 2026-06-01T18:00:36.712Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z FDA Considers Adding Peptides to Bulk Drug Compounding List https://novapharmanews.com/uploads/articles/fda-peptides-bulk-drug-compounding.webp FDA Considers Adding Peptides to Bulk Drug Compounding List https://novapharmanews.com/us/news/us-fda-proposes-regulations-weight-loss-drug-compounding 2026-06-01T18:00:36.547Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z US FDA Proposes New Regulations on Weight-Loss Drug Compounding semaglutide, liraglutide, weight loss https://novapharmanews.com/uploads/articles/us-fda-proposes-regulations-weight-loss-drug-compounding.webp US FDA Proposes New Regulations on Weight-Loss Drug Compounding https://novapharmanews.com/us/news/fda-flashback-breast-cancer-april-2026 2026-06-01T15:05:59.170Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z FDA Flashback: Key Breast Cancer Decisions from April 2026 oncology, breast cancer https://novapharmanews.com/uploads/articles/fda-flashback-breast-cancer-april-2026.webp FDA Flashback: Key Breast Cancer Decisions from April 2026 https://novapharmanews.com/us/news/top-biotech-gainers-codx-nrxp-nvax-clinical-trials-update 2026-06-01T15:06:07.978Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z Top Biotech Gainers: CODX, NRXP, NVAX - Clinical Trials Update CODX, NRXP, NVAX, Ebola https://novapharmanews.com/uploads/articles/top-biotech-gainers-codx-nrxp-nvax-clinical-trials-update.webp Top Biotech Gainers: CODX, NRXP, NVAX - Clinical Trials Update https://novapharmanews.com/us/news/fda-easing-restrictions-unproven-peptides 2026-06-01T08:55:35.466Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z FDA Considers Easing Restrictions on Unproven Peptides https://novapharmanews.com/uploads/articles/fda-easing-restrictions-unproven-peptides.webp FDA Considers Easing Restrictions on Unproven Peptides https://novapharmanews.com/us/news/eli-lilly-acquires-centessa-pharmaceuticals-market-analysis 2026-06-01T17:01:16.691Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z Eli Lilly Acquires Centessa Pharmaceuticals: Market Analysis https://novapharmanews.com/uploads/articles/eli-lilly-acquires-centessa-pharmaceuticals-market-analysis.webp Eli Lilly Acquires Centessa Pharmaceuticals: Market Analysis https://novapharmanews.com/us/news/bayer-acquisition-eye-drug-biotech 2026-06-01T18:02:41.958Z NovaPharmaNews en-US 2026-06-01T06:15:59.933Z Bayer's $300M Acquisition: A Strategic Move in Ophthalmology https://novapharmanews.com/uploads/articles/bayer-acquisition-eye-drug-biotech.webp Bayer's $300M Acquisition: A Strategic Move in Ophthalmology https://novapharmanews.com/us/news/fsma-final-rule-traceability-requirements 2026-06-01T18:00:36.499Z NovaPharmaNews en-US 2026-06-01T06:15:53.438Z FSMA Final Rule: New Traceability Requirements Impacting Food Safety https://novapharmanews.com/uploads/articles/fsma-final-rule-traceability-requirements.webp FSMA Final Rule: New Traceability Requirements Impacting Food Safety https://novapharmanews.com/us/news/fda-guidance-next-gen-sequencing-gene-therapy-safety 2026-06-01T18:18:43.661Z NovaPharmaNews en-US 2026-06-01T06:15:53.438Z FDA Guidance on Next-Gen Sequencing for Gene Therapy Safety gene therapy https://novapharmanews.com/uploads/articles/fda-guidance-next-gen-sequencing-gene-therapy-safety.webp FDA Guidance on Next-Gen Sequencing for Gene Therapy Safety https://novapharmanews.com/apac/news/pharmaceuticals-market-size-share-analysis-2034 2026-06-01T13:43:14.501Z NovaPharmaNews en-AU 2026-06-01T06:15:53.438Z Pharmaceuticals Market Size and Share Analysis for 2034 https://novapharmanews.com/uploads/articles/pharmaceuticals-market-size-share-analysis-2034.webp Pharmaceuticals Market Size and Share Analysis for 2034 https://novapharmanews.com/apac/news/early-access-disparities-innovative-therapies 2026-06-01T17:54:54.895Z NovaPharmaNews en-AU 2026-06-01T06:15:53.438Z Disparities in Early Access to Innovative Therapies: A Global Overview https://novapharmanews.com/uploads/articles/early-access-disparities-innovative-therapies.webp Disparities in Early Access to Innovative Therapies: A Global Overview https://novapharmanews.com/apac/news/beone-medicines-phase-3-herizon-gea-data-nejm 2026-06-01T17:54:55.958Z NovaPharmaNews en-AU 2026-06-01T06:15:53.438Z BeOne Medicines Phase 3 HERIZON-GEA Data Published in NEJM oncology https://novapharmanews.com/uploads/articles/beone-medicines-phase-3-herizon-gea-data-nejm.webp BeOne Medicines Phase 3 HERIZON-GEA Data Published in NEJM https://novapharmanews.com/eu/news/rethinking-qa-qc-future-bio-pharmaceutical-analysis-2026 2026-06-01T12:49:31.016Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z Rethinking QA/QC at The Future of Bio/Pharmaceutical Analysis 2026 https://novapharmanews.com/uploads/articles/rethinking-qa-qc-future-bio-pharmaceutical-analysis-2026.webp Rethinking QA/QC at The Future of Bio/Pharmaceutical Analysis 2026 https://novapharmanews.com/apac/news/akeso-lung-cancer-drug-outperforms-immunotherapy 2026-06-01T17:54:57.503Z NovaPharmaNews en-AU 2026-06-01T06:15:53.438Z Akeso Lung Cancer Drug Outperforms Immunotherapy in China Trial oncology, lung cancer https://novapharmanews.com/uploads/articles/akeso-lung-cancer-drug-outperforms-immunotherapy.webp Akeso Lung Cancer Drug Outperforms Immunotherapy in China Trial https://novapharmanews.com/eu/news/ascentage-pharma-eha-2026-clinical-advances 2026-06-01T17:43:23.287Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z Ascentage Pharma's 17 Clinical Advances at EHA 2026 https://novapharmanews.com/uploads/articles/ascentage-pharma-eha-2026-clinical-advances.webp Ascentage Pharma's 17 Clinical Advances at EHA 2026 https://novapharmanews.com/eu/news/who-europe-access-novel-medicines 2026-06-01T18:29:55.480Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z WHO/Europe's Initiative on Access to Novel Medicines https://novapharmanews.com/uploads/articles/who-europe-access-novel-medicines.webp WHO/Europe's Initiative on Access to Novel Medicines https://novapharmanews.com/eu/news/fda-delays-astrazeneca-breast-cancer-drug-review 2026-06-01T18:30:54.068Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z FDA Delays AstraZeneca's Breast Cancer Drug Review: Key Insights breast cancer https://novapharmanews.com/uploads/articles/fda-delays-astrazeneca-breast-cancer-drug-review.webp FDA Delays AstraZeneca's Breast Cancer Drug Review: Key Insights https://novapharmanews.com/eu/news/us-europe-biosimilar-approvals-2026 2026-06-01T18:27:32.292Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z Biosimilar Approvals: U.S. vs. Europe Insights https://novapharmanews.com/uploads/articles/us-europe-biosimilar-approvals-2026.webp Biosimilar Approvals: U.S. vs. Europe Insights https://novapharmanews.com/eu/news/2026-italy-drug-medical-device-litigation-report 2026-06-01T13:43:13.600Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z 2026 Italy Drug & Medical Device Litigation Report: Key Insights https://novapharmanews.com/uploads/articles/2026-italy-drug-medical-device-litigation-report.webp 2026 Italy Drug & Medical Device Litigation Report: Key Insights https://novapharmanews.com/eu/news/datroway-priority-review-metastatic-tnbc 2026-06-01T16:14:42.438Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z Datroway Receives Priority Review for Metastatic Triple-Negative Breast Cancer Datroway, oncology, breast cancer, metastatic triple-negative breast cancer https://novapharmanews.com/uploads/articles/datroway-priority-review-metastatic-tnbc.webp Datroway Receives Priority Review for Metastatic Triple-Negative Breast Cancer https://novapharmanews.com/eu/news/horizon-scanning-ema-regulatory-updates 2026-06-01T16:51:15.662Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z Horizon Scanning at EMA: Regulatory Updates for Future Medicines https://novapharmanews.com/uploads/articles/horizon-scanning-ema-regulatory-updates.webp Horizon Scanning at EMA: Regulatory Updates for Future Medicines https://novapharmanews.com/eu/news/international-school-clinical-oncology-annual-congress-2026 2026-06-01T12:49:46.623Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z International School of Clinical Oncology Annual Congress 2026: Key Insights oncology https://novapharmanews.com/uploads/articles/international-school-clinical-oncology-annual-congress-2026.webp International School of Clinical Oncology Annual Congress 2026: Key Insights https://novapharmanews.com/eu/news/bio-pharma-outlook-2026-regulatory-updates 2026-06-01T07:48:53.642Z NovaPharmaNews en-GB 2026-06-01T06:15:53.438Z Bio/Pharma Outlook 2026: Regulatory Updates and Implications https://novapharmanews.com/uploads/articles/bio-pharma-outlook-2026-regulatory-updates.webp Bio/Pharma Outlook 2026: Regulatory Updates and Implications https://novapharmanews.com/apac/news/decade-ai-medical-device-regulation-2015-2025 2026-06-01T18:16:59.196Z NovaPharmaNews en-AU 2026-06-01T06:15:53.438Z A Decade of AI Medical Device Regulation: Key Updates https://novapharmanews.com/uploads/articles/decade-ai-medical-device-regulation-2015-2025.webp A Decade of AI Medical Device Regulation: Key Updates https://novapharmanews.com/apac/news/newron-pharmaceuticals-june-investor-conferences 2026-06-01T18:16:58.584Z NovaPharmaNews en-AU 2026-06-01T06:15:53.438Z Newron Pharmaceuticals to Participate in June Investor Conferences https://novapharmanews.com/uploads/articles/newron-pharmaceuticals-june-investor-conferences.webp Newron Pharmaceuticals to Participate in June Investor Conferences https://novapharmanews.com/us/news/healthcare-dealmaker-megamergers-2026 2026-06-01T17:59:36.577Z NovaPharmaNews en-US 2026-06-01T06:15:53.438Z Healthcare Dealmakers Target Megamergers in 2026 https://novapharmanews.com/uploads/articles/healthcare-dealmaker-megamergers-2026.webp Healthcare Dealmakers Target Megamergers in 2026 https://novapharmanews.com/us/news/pharma-in-focus-regulatory-updates 2026-06-01T08:57:22.087Z NovaPharmaNews en-US 2026-06-01T06:15:53.438Z Pharma in Focus: Regulatory Updates You Need to Know https://novapharmanews.com/uploads/articles/pharma-in-focus-regulatory-updates.webp Pharma in Focus: Regulatory Updates You Need to Know https://novapharmanews.com/us/news/china-approves-hernexeos-lung-cancer-treatment 2026-06-01T17:06:16.788Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z China Approves HERNEXEOS for Lung Cancer Treatment HERNEXEOS, oncology, lung cancer https://novapharmanews.com/uploads/articles/china-approves-hernexeos-lung-cancer-treatment.webp China Approves HERNEXEOS for Lung Cancer Treatment https://novapharmanews.com/us/news/resilience-reinvention-biotech-maturity 2026-06-01T08:21:17.752Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z Resilience and Reinvention: Biotech’s Year of Maturity https://novapharmanews.com/uploads/articles/resilience-reinvention-biotech-maturity.webp Resilience and Reinvention: Biotech’s Year of Maturity https://novapharmanews.com/us/news/vir-astellas-240m-prostate-cancer-trials 2026-06-01T10:13:51.579Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z Vir-Astellas Secures $240M for Prostate Cancer Trials prostate cancer https://novapharmanews.com/uploads/articles/vir-astellas-240m-prostate-cancer-trials.webp Vir-Astellas Secures $240M for Prostate Cancer Trials https://novapharmanews.com/us/news/global-ma-trends-health-industries-2026-outlook 2026-06-01T18:02:39.768Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z Global M&A Trends in Health Industries: 2026 Outlook https://novapharmanews.com/uploads/articles/global-ma-trends-health-industries-2026-outlook.webp Global M&A Trends in Health Industries: 2026 Outlook https://novapharmanews.com/us/news/fda-decisions-q2-2026-drug-approvals 2026-06-01T12:08:52.272Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z 5 FDA Drug Approvals to Watch in 2026 https://novapharmanews.com/uploads/articles/fda-drug-approvals-2026.webp 5 FDA Drug Approvals to Watch in 2026 https://novapharmanews.com/us/news/longeveron-q1-2026-financial-results-business-update 2026-06-01T05:44:14.516Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z Longeveron Reports Q1 2026 Financial Results and Business Update https://novapharmanews.com/uploads/articles/longeveron-q1-2026-financial-results-business-update.webp Longeveron Reports Q1 2026 Financial Results and Business Update https://novapharmanews.com/us/news/china-drug-development-oncology-us 2026-06-01T14:33:45.495Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z China’s Rise in Drug Development Looms Over U.S. Oncology Market oncology https://novapharmanews.com/uploads/articles/china-drug-development-oncology-us.webp China’s Rise in Drug Development Looms Over U.S. Oncology Market https://novapharmanews.com/us/news/altrx-glp-1-review-2026-fda-updates-semaglutide 2026-06-01T07:19:34.926Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z altRx GLP-1 Review 2026: FDA Updates on Semaglutide semaglutide, GLP-1 https://novapharmanews.com/uploads/articles/altrx-glp-1-review-2026-fda-updates-semaglutide.webp altRx GLP-1 Review 2026: FDA Updates on Semaglutide https://novapharmanews.com/us/news/chinese-pharma-innovators-global-expansion 2026-06-01T18:08:21.556Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z Chinese Pharma Innovators Expand Globally with Innovative Deal Structures https://novapharmanews.com/uploads/articles/chinese-pharma-innovators-global-expansion.webp Chinese Pharma Innovators Expand Globally with Innovative Deal Structures https://novapharmanews.com/us/news/pennsylvania-compounding-pharmacy-fda-warning-letter 2026-06-01T09:35:44.709Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z Pennsylvania Compounding Pharmacy Receives FDA Warning Letter https://novapharmanews.com/uploads/articles/pennsylvania-compounding-pharmacy-fda-warning-letter.webp Pennsylvania Compounding Pharmacy Receives FDA Warning Letter https://novapharmanews.com/us/news/jpm26-biotech-ma-insights-market-analysis 2026-06-01T06:58:51.634Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z JPM26: Biotech M&A Insights and Market Analysis https://novapharmanews.com/uploads/articles/jpm26-biotech-ma-insights-market-analysis.webp JPM26: Biotech M&A Insights and Market Analysis https://novapharmanews.com/us/news/wockhardt-us-fda-approval-zaynich 2026-05-31T19:00:59.475Z NovaPharmaNews en-US 2026-05-31T05:30:08.880Z Wockhardt Secures US FDA Approval for ZAYNICH: A Milestone for Indian Pharma ZAYNICH https://novapharmanews.com/uploads/articles/wockhardt-us-fda-approval-zaynich.webp Wockhardt Secures US FDA Approval for ZAYNICH: A Milestone for Indian Pharma https://novapharmanews.com/eu/news/owkin-astrazeneca-ai-collaboration-drug-research 2026-06-01T14:09:35.455Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z Owkin and AstraZeneca Enhance AI Collaboration for Drug Research https://novapharmanews.com/uploads/articles/owkin-astrazeneca-ai-collaboration-drug-research.webp Owkin and AstraZeneca Enhance AI Collaboration for Drug Research https://novapharmanews.com/eu/news/esmo-asia-nadia-harbeck-oncology-advances 2026-06-01T17:32:53.227Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z Insights from ESMO Asia: Nadia Harbeck on Oncology Advances oncology https://novapharmanews.com/uploads/articles/esmo-asia-nadia-harbeck-oncology-advances.webp Insights from ESMO Asia: Nadia Harbeck on Oncology Advances https://novapharmanews.com/eu/news/cancer-therapy-ost-her2-2026-ema-call 2026-06-01T08:54:50.553Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z Cancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data OST-HER2, cancer https://novapharmanews.com/uploads/articles/cancer-therapy-ost-her2-2026-ema-call.webp Cancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data https://novapharmanews.com/eu/news/innovent-pfizer-cancer-drug-deal 2026-06-01T16:02:01.360Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z Innovent Biologics and Pfizer's $10.5 Billion Cancer Drug Deal cancer https://novapharmanews.com/uploads/articles/innovent-pfizer-cancer-drug-deal.webp Innovent Biologics and Pfizer's $10.5 Billion Cancer Drug Deal https://novapharmanews.com/eu/news/25-posts-not-to-miss-elcc-2026-oncology 2026-06-01T18:28:55.837Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z 25 Posts Not To Miss From ELCC 2026: Oncology Insights oncology https://novapharmanews.com/uploads/articles/25-posts-not-to-miss-elcc-2026-oncology.webp 25 Posts Not To Miss From ELCC 2026: Oncology Insights https://novapharmanews.com/eu/news/chmp-negative-stance-acadia-rett-syndrome-drug 2026-06-01T13:56:41.273Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z CHMP's Negative Stance on Acadia's Rett Syndrome Drug Acadia, Rett syndrome https://novapharmanews.com/uploads/articles/chmp-negative-stance-acadia-rett-syndrome-drug.webp CHMP's Negative Stance on Acadia's Rett Syndrome Drug https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-clinical-data-eas-congress 2026-06-01T08:56:03.046Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z Arrowhead Pharmaceuticals Unveils Positive Clinical Data at EAS Congress cardiometabolic disorders https://novapharmanews.com/uploads/articles/arrowhead-pharmaceuticals-positive-clinical-data-eas-congress.webp Arrowhead Pharmaceuticals Unveils Positive Clinical Data at EAS Congress https://novapharmanews.com/eu/news/lenz-therapeutics-vizz-ema-presbyopia 2026-06-01T09:34:47.575Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z LENZ Therapeutics Submits VIZZ® Application to EMA for Presbyopia VIZZ, Presbyopia https://novapharmanews.com/uploads/articles/lenz-therapeutics-vizz-ema-presbyopia.webp LENZ Therapeutics Submits VIZZ® Application to EMA for Presbyopia https://novapharmanews.com/eu/news/privosegtor-ema-prime-optic-neuritis 2026-06-01T07:54:45.467Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z Privosegtor Secures EMA PRIME Designation for Optic Neuritis optic neuritis https://novapharmanews.com/uploads/articles/privosegtor-ema-prime-optic-neuritis.webp Privosegtor Secures EMA PRIME Designation for Optic Neuritis https://novapharmanews.com/eu/news/innovent-biologics-shares-surge-pfizer-deal 2026-06-01T16:55:57.753Z NovaPharmaNews en-GB 2026-05-31T05:30:01.835Z Innovent Biologics Shares Surge 10% Following Pfizer Deal https://novapharmanews.com/uploads/articles/innovent-biologics-shares-surge-pfizer-deal.webp Innovent Biologics Shares Surge 10% Following Pfizer Deal https://novapharmanews.com/us/news/lilly-38b-investment-infectious-disease-portfolio 2026-06-01T15:24:13.905Z NovaPharmaNews en-US 2026-05-31T05:30:01.835Z Eli Lilly's $3.8B Investment in Infectious Disease Portfolio infectious diseases https://novapharmanews.com/uploads/articles/lilly-38b-investment-infectious-disease-portfolio.webp Eli Lilly's $3.8B Investment in Infectious Disease Portfolio https://novapharmanews.com/us/news/fda-device-guidance-agenda-2026 2026-06-01T08:52:40.226Z NovaPharmaNews en-US 2026-05-31T05:30:01.835Z FDA Device Guidance Agenda: Key Regulatory Updates for 2026 https://novapharmanews.com/uploads/articles/fda-device-guidance-agenda-2026.webp FDA Device Guidance Agenda: Key Regulatory Updates for 2026 https://novapharmanews.com/us/news/fda-blueprint-regulatory-risk-animal-testing-alternatives 2026-05-31T08:02:53.289Z NovaPharmaNews en-US 2026-05-31T05:30:01.835Z FDA Blueprint to Reduce Regulatory Risks for Animal Testing Alternatives https://novapharmanews.com/uploads/articles/fda-blueprint-regulatory-risk-animal-testing-alternatives.webp FDA Blueprint to Reduce Regulatory Risks for Animal Testing Alternatives https://novapharmanews.com/us/news/fda-new-guidance-ai-regulatory-restraint 2026-06-01T14:25:36.216Z NovaPharmaNews en-US 2026-05-31T05:30:01.835Z FDA's New Guidance on AI: Regulatory Restraint Explained https://novapharmanews.com/uploads/articles/fda-new-guidance-ai-regulatory-restraint.webp FDA's New Guidance on AI: Regulatory Restraint Explained https://novapharmanews.com/apac/news/smarter-medical-devices-ecosystem-india-regulatory-updates 2026-06-01T16:56:06.528Z NovaPharmaNews en-AU 2026-05-31T05:30:01.835Z Building a Smarter Medical Devices Ecosystem in India: Regulatory Updates https://novapharmanews.com/uploads/articles/smarter-medical-devices-ecosystem-india-regulatory-updates.webp Building a Smarter Medical Devices Ecosystem in India: Regulatory Updates https://novapharmanews.com/apac/news/uk-clinical-trials-oncology-impact 2026-06-01T18:16:57.175Z NovaPharmaNews en-AU 2026-05-31T05:30:01.835Z UK Clinical Trials in Oncology: Actions Driving Impact oncology https://novapharmanews.com/uploads/articles/uk-clinical-trials-oncology-impact.webp UK Clinical Trials in Oncology: Actions Driving Impact https://novapharmanews.com/apac/news/biomarkers-digital-technologies-oncology-asia-2026 2026-06-01T18:16:37.370Z NovaPharmaNews en-AU 2026-05-31T05:30:01.835Z Biomarkers and Digital Technologies Transforming Oncology in Asia oncology https://novapharmanews.com/uploads/articles/biomarkers-digital-technologies-oncology-asia-2026.webp Biomarkers and Digital Technologies Transforming Oncology in Asia https://novapharmanews.com/apac/news/innovative-oncology-pharma-china 2026-06-01T18:16:16.185Z NovaPharmaNews en-AU 2026-05-31T05:30:01.835Z Innovative Oncology Pharma Companies in China: A Look Ahead oncology https://novapharmanews.com/uploads/articles/innovative-oncology-pharma-china.webp Innovative Oncology Pharma Companies in China: A Look Ahead https://novapharmanews.com/apac/news/asia-pacific-eclinical-solutions-market-report-2025-2030 2026-06-01T18:17:28.098Z NovaPharmaNews en-AU 2026-05-31T05:30:01.835Z Asia Pacific eClinical Solutions Market Report 2025-2030: Key Insights https://novapharmanews.com/uploads/articles/asia-pacific-eclinical-solutions-market-report-2025-2030.webp Asia Pacific eClinical Solutions Market Report 2025-2030: Key Insights